Literature DB >> 10877541

Growth hormone as an immunomodulating therapeutic agent.

W J Murphy1, D L Longo.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10877541     DOI: 10.1016/s0167-5699(00)01594-2

Source DB:  PubMed          Journal:  Immunol Today        ISSN: 0167-5699


× No keyword cloud information.
  8 in total

Review 1.  A challenge for the future: aging and HIV infection.

Authors:  Tammy M Rickabaugh; Beth D Jamieson
Journal:  Immunol Res       Date:  2010-12       Impact factor: 2.829

Review 2.  Clinical strategies to enhance T cell reconstitution.

Authors:  Gabrielle L Goldberg; Johannes L Zakrzewski; Miguel A Perales; Marcel R M van den Brink
Journal:  Semin Immunol       Date:  2007-10-26       Impact factor: 11.130

Review 3.  Thymic rejuvenation and aging.

Authors:  Melissa S Ventevogel; Gregory D Sempowski
Journal:  Curr Opin Immunol       Date:  2013-07-04       Impact factor: 7.486

4.  Agarose surface coating influences intracellular accumulation and enhances payload stability of a nano-delivery system.

Authors:  Enrica De Rosa; Ciro Chiappini; Dongmei Fan; Xuewu Liu; Mauro Ferrari; Ennio Tasciotti
Journal:  Pharm Res       Date:  2011-05-24       Impact factor: 4.200

5.  Growth hormone therapy in pediatric kidney transplantation-the long-term clinical benefits beyond improvement of growth after withdrawal of pre-transplant therapy.

Authors:  Ryszard Grenda
Journal:  Pediatr Nephrol       Date:  2021-09-20       Impact factor: 3.651

6.  Growth hormone resurrects adult human thymus during HIV-1 infection.

Authors:  Kiki Tesselaar; Frank Miedema
Journal:  J Clin Invest       Date:  2008-03       Impact factor: 14.808

7.  Growth hormone protects human lymphocytes from irradiation-induced cell death.

Authors:  Laurence Lempereur; Daria Brambilla; Giovanna Maria Scoto; Maria D'Alcamo; Vincent Goffin; Lucia Crosta; Tullio Palmucci; Liborio Rampello; Renato Bernardini; Giuseppina Cantarella
Journal:  Br J Pharmacol       Date:  2003-04       Impact factor: 8.739

8.  Loss of the CD56hiCD16- NK cell subset and NK cell interferon-gamma production during antiretroviral therapy for HIV-1: partial recovery by human growth hormone.

Authors:  M R Goodier; N Imami; G Moyle; B Gazzard; F Gotch
Journal:  Clin Exp Immunol       Date:  2003-12       Impact factor: 4.330

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.